L- MAI - SAY NO TO ALLERGY!

Allergy is one of the most widespread pathologies in the world. Allergic rhinitis and urticaria are among the most common allergic diseases. Thus, 20-40% of the world's population suffers from allergic rhinitis.2.3 At least once in a lifetime every fifth person had suffered from urticarial. 4.5.

We call your attention to a new preparation against allergic rhinitis and urticarial - L-MAI (levocetirizine). This effective third-generation antihistamine has anti-allergic, anti-exudate, antipruritic, and anti-inflammatory properties. Thanks to these properties L-MAI acts fast1 and tackles the main symptoms for a long period of time (plasma elimination half-life of levocetirizine in adults is 7.9 ± 1.9 hours)6 of these two above mentioned allergic diseases: rhinorrhea, nasal congestion, sneezing, nasal itching, as well as blisters and itching of the skin.

The most important advantage of L-MAI is that it begins to act starting from the 12th minute!1 L-MAI may be used by the whole family: adults and children over 2 years old. There is no need to buy several antihistamines - one vial of drops will suffice for a long time (20 ml = 400 drops). Different dosage are for different age groups:


AGE

SINGLE DOSE AND DOSING FREQUENCY

DAILY DOSE

2–6 years

1,25 mg (5 drops) 2 times a day

2,5 mg (10 drops)

6 years of age and over

5 mg (20 drops) once a day

5 mg (20 drops)


Unlike antihistamines in the form of syrups L-MAI drops do not contain: sugar and dyes.6

L-MAI drops may be takes both diluted and undiluted without water. L-MAI is up to date and convenient for the treatment of any form of allergic rhinitis and urticarial.

L- MAI - SAY NO TO ALLERGY! BEGINS TO ACT FROM THE 12TH MINUTE! 1

Advertising of Medicinal Product

Always check with your doctor before using the medicinal product and read carefully the patient instruction leaflet of the medicinal products for human use. There are contraindications and side effects.

Manufacturer and applicant: Joint Ukrainian-Spanish Enterprise “Sperco Ukraine”,

25, 600-richia str., Vinnytsia, Ukraine, 21027, tel/fax (0432) 52 30 49

Marketing authorization MOH of Ukraine UA/17438/01/01 of 29.05.2019.

©2019 Joint Ukrainian-Spanish Enterprise “Sperco Ukraine”. All rights reserved.

Self-medication may cause serious health hazards.

1.  In studies of the original levocetirizine the effect starts in 12 minutes after taking a single dose in 50% of patients (Instructions for the medical use of L-MAI).

2.  Holmström M, Davidsson Å, Hellgren J. Allergic rhinitis affects one third of the population. Lakartidningen. 2016 Apr 5;113.

3.  Seidman MD, Gurgel RK, Lin SY et al. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg. 2015 Feb;152(1 Suppl):S1-43.

4.  Saini S.S. Chronic spontaneous urticaria: etiology and pathogenesis. Immunol Allergy Clin North Am. 2014 Feb;34(1):33-52.

5.  Schaefer P. Acute and Chronic Urticaria: Evaluation and Treatment. Am Fam Physician. 2017 Jun 1;95(11):717-724.

6.  Instructions for the medical use of L-MAI


BaDM - We work for you!

Regional offices